在青少年时期接受青春期抑制治疗后,跨性别成年人的性满足和功能障碍
Isabelle S van der Meulen1,2, Marijn Arnoldussen1,2, Anna I R van der Miesen1,2
1Department of Child and Adolescent Psychiatry, Amsterdam University Medical Center, 1081 HV Amsterdam, The Netherlands.
The journal of sexual medicine
|June 27, 2025
概括
跨性别和性别多样性个体的青春期抑制 (PS) 治疗不会对长期的性满意度或功能产生负面影响. 接受早期或晚期PS的患者的结果与晚期开始接受性别确认护理的成年人相似且可比.
科学领域:
- 内分泌学 在内分泌学.
- 生殖健康 生殖健康
- 确认性别的护理
背景情况:
- 在青春期抑制 (PS) 后,跨性别和性别多元 (TGD) 个体的性满意度和功能障碍未得到充分研究.
- 人们担心早期内分泌干预对性健康的长期影响.
研究的目的:
- 研究早期青春期抑制 (PS) 治疗对TGD个体的性满意度和功能障碍的长期影响.
- 为了比较早期和晚期PS治疗组之间的结果,以及在成年后开始与性别相关的医疗治疗 (GRMT) 的队列.
主要方法:
- 70名TGD患者 (50名跨男性,20名跨女性) 接受PS和性别确认激素 (GAH) 治疗的回顾性队列研究.
- 评估性经验使用自主开发的问卷至少9年后GAH.
- 早期和晚期PS群体之间的比较以及与历史跨性别群体的比较.
主要成果:
- 52%的变性男性和40%的变性女性报告性满意度,早期和晚期PS组之间没有显著差异.
- 58%的变性男性报告性功能障碍 (最常见的是:难以开始性接触) 和50%的变性女性报告性功能障碍 (最常见的是:难以达到高潮).
- 性功能障碍的患病率在PS组和在成年时开始GRMT的跨性别个人之间是可比的.
结论:
- 大多数接受PS治疗的TGD患者没有经历长期性困难.
- 对性满意度和性功能的结果是相似的,不管是早期还是晚期的PS启动,与成人开始GRMT的人相似.
- 这些发现可能会减轻人们对内分泌GRMT对性健康的影响的担忧,尽管性咨询仍然很重要.
相关概念视频
Psychosexual Stages of Personality: Genital
1.1K
The genital stage is the final phase of Sigmund Freud's theory of psychosexual development, beginning at puberty, around age 12. During this stage, sexual energy shifts from self-focused interests to external individuals, marking the development of mature adult sexuality. Freud saw this phase as a time of sexual reawakening, with desires directed toward others outside the family. A healthy transition into this stage, according to Freud, signifies the emergence of two key aspects of adult...
1.1K
Signs of Puberty
628
Puberty is a critical phase, typically beginning between the ages of 8 and 13 in girls and 9 and 14 in boys, though timing can vary based on genetics, environmental factors, and overall health. This period is characterized by the development of secondary sexual characteristics and the attainment of reproductive potential. Endocrine changes underpin puberty, with hormonal surges of Luteinizing Hormone (LH) and Follicle-Stimulating Hormone (FSH) instigated by Gonadotropin-Releasing Hormone (GnRH)...
628
Psychosexual Theory of Development
699
Sigmund Freud's psychosexual theory of development suggests that early childhood experiences significantly shape personality and behavior. Freud proposed that development is discontinuous, occurring in five distinct stages, each defined by a focus on different erogenous zones. He believed that failure to resolve the conflicts specific to each stage successfully could result in fixation, potentially influencing behavior as adults.
The Five Stages of Psychosexual Development
Freud's psychosexual...
The Five Stages of Psychosexual Development
Freud's psychosexual...
699
Psychosexual Stages of Personality: Latency
706
Following the phallic stage in Freud's theory of psychosexual development, children enter a phase called the latency period, which lasts from approximately six to twelve years of age. Unlike earlier stages, where sexual impulses played a central role, Freud believed these impulses are repressed during the latency period, becoming part of the unconscious. This stage is often described as a time of psychological calm after the turbulence of the phallic stage.
The latency period is not...
The latency period is not...
706
Psychosexual Stages of Personality: Phallic
1.0K
The third stage of psychosexual development proposed by Freud is the phallic stage, occurring between the ages of 3 and 6. During this period, children become aware of their bodies and the differences between males and females. The erogenous zone in this stage is the genitals, and conflicts arise as children develop desires toward the opposite-sex parent. Boys experience the Oedipus complex, where they desire their mother and view their father as a rival. This leads to castration anxiety, the...
1.0K
Menopause
257
Menopause, a natural biological process marking the end of a woman's fertility, typically occurs between the fifth and sixth decade of life. This phase is characterized by the exhaustion of the ovarian follicle pool, leading to less responsive ovaries despite the high levels of Follicle Stimulating Hormone (FSH) and Luteinizing Hormone (LH). The consequential decrease in estrogen production results in symptoms like hot flashes, heavy sweating, headaches, hair loss, muscle pains, vaginal...
257


